The Times Australia
Fisher and Paykel Appliances
The Times World News

.

We are closer than ever to being able to 3D print medicines. Here's why that's important

  • Written by Amirali Popat, Associate Professor and Director of Research, The University of Queensland
We are closer than ever to being able to 3D print medicines. Here's why that's important

3D-printed medicine could be the future of personalised healthcare, with research now suggesting printed tablets have reached a sufficient quality to match the standards set for conventionally manufactured tablets.

Our new study[1], published in the International Journal of Pharmaceutics, highlights the promise 3D-printed medicines hold for patients.

If we can scale 3D printing to everyday use, the near limitless potential to have medicines customised to your specific health needs may become a reality sooner than you think.

One size doesn’t fit all

For a long time, medicines have been produced with what you might call a “one-size-fits-all” approach, whereby tablets and capsules come in only a set number of doses. But what if those exact doses don’t work for you?

Taking too much or too little of your medication can be hard to avoid when it only comes in set doses. This can have serious consequences when taking important medications such as antidepressants that trigger side effects when the dose is changed too quickly.

The traditional solution to these scenarios has been to try and break the tablet into halves or quarters to get a dose in-between. But this isn’t possible for every tablet, and even if it is, research shows it often ends up with an inaccurate dose[2].

3D printing can take away the guesswork and provide flexibility for health professionals to truly personalise medicine suited to you.

Read more: Health Check: is it OK to chew or crush your medicine?[3]

Layer by layer

You may have seen 3D printers producing toys, medical devices[4] and even food[5].

The printing of medicines uses the same technology, building a tablet one layer at a time by melting the medication combined with other approved ingredients to help it dissolve in the stomach. Importantly, the tablet can be 3D printed at any required dose by giving instructions to the machine to print it bigger or smaller.

In our proof of concept study we were able to 3D print tablets containing very accurate doses of caffeine, in a way that would be exceedingly difficult with conventional manufacturing methods.

Rather than choosing a dose based on limited commercial options, we selected the dose first and then designed and printed the tablet accordingly.

A pile of yellow coloured oval wafers on a purple background
A pile of the finished 3D-printed tablets. Liam Krueger, Author provided

While not often thought of as a medicine, the choice of caffeine in this research is important because it is the most widely used behavioural drug worldwide. Trying to cut down on caffeine often causes headaches and nausea because of the challenges in lowering the dose correctly. This is one of many scenarios where a one-size-fits-all approach would fall short.

Compared to attempts to split a conventional caffeine tablet into the same doses, the 3D-printed tablets proved to have far more accurate dosage.

Our results demonstrate a straightforward process for producing “the right medicine for the right patient at the right time”. This is one of the guiding principles of personalised medicine[6].

Read more: How cancer doctors use personalised medicine to target variations unique to each tumour[7]

A healthcare evolution

Although 3D printing has been around for decades, its use for producing medicines – especially in a hospital or pharmacy environment – is very new.

Australia has rigorous quality control standards for medicines thanks to regulation by the Therapeutic Goods Administration, and it is too early to tell how it will regulate 3D printed medicines.

The United States already has one 3D-printed seizure medication, Spritam, approved by the Food and Drug Administration (FDA). The printing process helps the resulting tablet rapidly disintegrate in the mouth[8] for patients who have trouble swallowing, but does not offer dose customisation.

However, it seems we are on the brink of customised approaches in the clinic, with three new 3D-printed medications[9] receiving FDA investigational new drug approval over 2021-22, and several other clinical trials[10] completed in the last few years.

We envision 3D printers in pharmacies and hospitals for on-site and true personalisation[11]. However, at this stage that doesn’t necessarily mean replacing or even competing with conventional medicines.

The production speed of current 3D printing technologies is much slower than conventional manufacturing. The greatest benefits will likely be for patients with particularly complicated medication regimens, or those taking certain types of medicines like antidepressants. Thus, the people who need it most could have their own tailor-made medicine.

In fact, the possibilities extend further than just choosing the right dose. The practice of pharmaceutical 3D printing could potentially include combining multiple drugs into a single “polypill[12]”, and fully customising features like shape, size, colour, or texture.

Video of a 3D printer laying down different colours in a single oval tablet
A timelapse video showing the proof of concept for a ‘polypill’. Liam Krueger, Author provided

We envision an evolution of digital healthcare where 3D printing is combined with technologies like machine learning[13], artificial intelligence and big data[14], taking our next big step towards truly personalised medicine.

This future will require a collaborative effort between researchers, health professionals, and regulatory bodies to define the place of 3D printing in healthcare, but could see us picking up our personalised medicine from a local pharmacy or hospital with the touch of a button.

References

  1. ^ Our new study (doi.org)
  2. ^ inaccurate dose (doi-org.ezproxy.library.uq.edu.au)
  3. ^ Health Check: is it OK to chew or crush your medicine? (theconversation.com)
  4. ^ medical devices (theconversation.com)
  5. ^ food (theconversation.com)
  6. ^ personalised medicine (doi.org)
  7. ^ How cancer doctors use personalised medicine to target variations unique to each tumour (theconversation.com)
  8. ^ rapidly disintegrate in the mouth (spritam.com)
  9. ^ new 3D-printed medications (pharmaceutical-journal.com)
  10. ^ clinical trials (www.fabrx.co.uk)
  11. ^ on-site and true personalisation (doi.org)
  12. ^ polypill (theconversation.com)
  13. ^ machine learning (theconversation.com)
  14. ^ big data (theconversation.com)

Read more https://theconversation.com/we-are-closer-than-ever-to-being-able-to-3d-print-medicines-heres-why-thats-important-208026

Times Magazine

Can bigger-is-better ‘scaling laws’ keep AI improving forever? History says we can’t be too sure

OpenAI chief executive Sam Altman – perhaps the most prominent face of the artificial intellig...

A backlash against AI imagery in ads may have begun as brands promote ‘human-made’

In a wave of new ads, brands like Heineken, Polaroid and Cadbury have started hating on artifici...

Home batteries now four times the size as new installers enter the market

Australians are investing in larger home battery set ups than ever before with data showing the ...

Q&A with Freya Alexander – the young artist transforming co-working spaces into creative galleries

As the current Artist in Residence at Hub Australia, Freya Alexander is bringing colour and creativi...

This Christmas, Give the Navman Gift That Never Stops Giving – Safety

Protect your loved one’s drives with a Navman Dash Cam.  This Christmas don’t just give – prote...

Yoto now available in Kmart and The Memo, bringing screen-free storytelling to Australian families

Yoto, the kids’ audio platform inspiring creativity and imagination around the world, has launched i...

The Times Features

Here’s what new debt-to-income home loan caps mean for banks and borrowers

For the first time ever, the Australian banking regulator has announced it will impose new debt-...

Why the Mortgage Industry Needs More Women (And What We're Actually Doing About It)

I've been in fintech and the mortgage industry for about a year and a half now. My background is i...

Inflation jumps in October, adding to pressure on government to make budget savings

Annual inflation rose[1] to a 16-month high of 3.8% in October, adding to pressure on the govern...

Transforming Addiction Treatment Marketing Across Australasia & Southeast Asia

In a competitive and highly regulated space like addiction treatment, standing out online is no sm...

Aiper Scuba X1 Robotic Pool Cleaner Review: Powerful Cleaning, Smart Design

If you’re anything like me, the dream is a pool that always looks swimmable without you having to ha...

YepAI Emerges as AI Dark Horse, Launches V3 SuperAgent to Revolutionize E-commerce

November 24, 2025 – YepAI today announced the launch of its V3 SuperAgent, an enhanced AI platf...

What SMEs Should Look For When Choosing a Shared Office in 2026

Small and medium-sized enterprises remain the backbone of Australia’s economy. As of mid-2024, sma...

Anthony Albanese Probably Won’t Lead Labor Into the Next Federal Election — So Who Will?

As Australia edges closer to the next federal election, a quiet but unmistakable shift is rippli...

Top doctors tip into AI medtech capital raise a second time as Aussie start up expands globally

Medow Health AI, an Australian start up developing AI native tools for specialist doctors to  auto...